Case Report on Anti-Tubercular Drug Induced Hepatoxicity / Modified ATT
1, 2, 3
- 1Department of Pharmacy Practice, Annai JKK Sampoorani Ammal College of Pharmacy, Erirmedu, Namakkal, Tamil Nadu, INDIA.
- 2Manager and Clinical Pharmacologist of Sun Rise Hospital, Kochi, Kerala, INDIA.
- 3Annai JKK Sampoorani Ammal College of Pharmacy, Tamil Nadu, INDIA.
CORRESPONDENCE
M Saru Khan
Department of Pharmacy Practice, Annai JKK Sampoorani Ammal College of Pharmacy, Erirmedu, Namakkal, Tamil Nadu, INDIA.
Volume 14, Issue 4 · pp. 294-297 · 2021 · DOI: 10.5530/ijopp.14.4.59
ABSTRACT
This case summary focusing on a 67-year male patient admitted in Sun rise Hospital, Kochi with k/c/o active tubercular on cat.2 ATT, now patient came complaint with c/o decreased appetite, food intake, nausea, vomiting and excessive fatigability. The patient was received first line anti tubercular drugs 6 months back RHZE (Rifampin, Pyrazinamide, Ethambutol, and Isoniazid) and discontinued medication 2 months back. Now it is developed a severe hepatitis which is an adverse drug reaction of the Antitubercular drugs.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Khan, M. S., Sunny, B., & Krishnan, R. M. (2021). Case Report on Anti-Tubercular Drug Induced Hepatoxicity / Modified ATT. Indian Journal of Pharmacy Practice, 14(4), 294-297. https://doi.org/10.5530/ijopp.14.4.59
Copyright and licence
© 2021 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. CC BY 4.0